共 99 条
- [1] Sjöström L(2013)Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery J Intern Med 273 219-34
- [2] James ND(2016)Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial Lancet 387 1163-1177
- [3] Sydes MR(2018)Bone health after bariatric surgery JBMR Plus 2 121-133
- [4] Clarke NW(2010)Bariatric surgery and bone metabolism: a systematic review Arq Bras Endocrinol Metabol 54 158-163
- [5] Gagnon C(2014)Bone loss after bariatric surgery: causes, consequences, and management Lancet Diabetes Endocrinol 2 165-174
- [6] Schafer AL(2018)High incidence of secondary hyperparathyroidism in bariatric patients: comparing different procedures Obes Surg 28 798-804
- [7] Viégas M(2015)Two-year changes in bone density after Roux-en-Y gastric bypass surgery J Clin Endocrinol Metab 100 1452-1459
- [8] de Vasconcelos RS(2018)Longitudinal 5-year evaluation of bone density and microarchitecture after Roux-en-Y gastric bypass surgery J Clin Endocrinol Metab 103 4104-4112
- [9] Neves AP(2020)Changes in bone metabolism after sleeve gastrectomy versus gastric bypass: a meta-analysis Obes Surg 30 77-86
- [10] Stein EM(2014)Fracture risk following bariatric surgery: a population-based study Osteoporos Int 25 151-158